Company profile
Cellebrite
Company mentioned in CyberMerge coverage.
- Status
- Public · CLBT
- Market cap
- Not recorded in CyberMerge data
- Latest funding
- Undisclosed
- CyberMerge Index
- #2 · score 93 Nov 12, 2026
- Last updated
Categories
No Research map or Startup Radar category recorded.
Funding & valuation
Funding: Undisclosed — no round recorded in the CyberMerge Funding Tracker.
Rankings
- CyberMerge Index · Nov 12, 2026 #2 · score 93. Earnings, sell-the-news: Q3 revenue of $149.0M (up 18%), ARR of $528.5M (up 20%) and non-GAAP EPS of $0.17 beat, and it raised its FY adjusted EBITDA outlook to $163–$166M. But it trimmed FY26 revenue to $553–$558M (from $555–$561M) as more revenue shifts to ratable cloud and… Source Daily momentum, not market cap.
Earnings Pulse
CLBT · 2026 Q3 Nov 12, 2026 — 0.5285 Source
On the desk
- Today's Deals · Earnings · Nov 12, 2026 Cellebrite beats on profit and ARR, but trims its FY revenue guide, and CLBT flips from +6% premarket to about -5%. Cellebrite Q3 2026 release / SEC 6-K, Nov 12, 2026; Investing.com; Kalkine; MarketBeat; Benzinga
Figures appear only as recorded in CyberMerge data, with source and date. “Undisclosed” means no published figure in our data. Editorial, not investment advice. Last updated . Spot an error? Tell the desk.